Catalyst Wire Dossier Catalyst Wire Dossier

TAXUS Paclitaxel-Eluting Stent

paclitaxel-eluting stent · Boston Scientific Corporation
Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for TAXUS Paclitaxel-Eluting Stent, covering 2006-10-20 to 2017-04-21. Get the full timeline:

Most recent: Clinical Trial Update: A Randomized, Double-blind Study to Assess Paclitaxel-eluting Stents in Treatment of Longer Lesions [Phase 2, Phase 3]

See pricing